| Dr Justin Carter, DDS | |
|
395 E 600 S, Preston, ID 83263-4901 | |
| (208) 852-0194 | |
| Not Available |
| Full Name | Dr Justin Carter |
|---|---|
| Gender | Male |
| Speciality | Dentist - General Practice |
| Location | 395 E 600 S, Preston, Idaho |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1386804458 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1223G0001X | Dentist - General Practice | 7000555-9922 (Utah) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Justin Carter, DDS 1415 N 800 W, Preston, ID 83263-5275 Ph: (435) 757-3332 | Dr Justin Carter, DDS 395 E 600 S, Preston, ID 83263-4901 Ph: (208) 852-0194 |
News Archive
Roche has announced that the European Commission has approved Avastin (bevacizumab, rhuMAb-VEGF), the new innovative anti-angiogenesis drug, for the treatment of patients with previously untreated metastatic colorectal cancer.
Antibiotic resistance in bottlenose dolphins shows that up to 88% of pathogenic organisms in this species is resistant to one or more antibiotics. This finding offers very useful insights into the identical phenomenon in humans. This species is termed a sentinel species, which means it reflects environmental risks to humans in advance of their occurrence in humans.
A novel drug, named "FerriIridium", can simultaneously help diagnose and treat gastric cancer. The initially weakly active precursor (prodrug), based on an iridium-containing compound, is selectively activated only after reaching the interior of a tumor cell. This is possible because of the higher amount of iron present there, report scientists in the journal Angewandte Chemie.
Lighthouse1, an industry leader in consumer-driven healthcare (CDH) software solutions, today announced a partnership with TSYS Healthcare to provide an integrated end-to-end healthcare payment solution. The partnership brings another fully integrated payment solution to CDH administrators using the Lighthouse1 OnDemand™ platform.
Cortex Pharmaceuticals, Inc. reported a net loss applicable to common stock of $3,243,000, or $0.06 per share for the quarter ended September 30, 2009 compared with a net loss applicable to common stock of $3,148,000, or $0.07 per share for the corresponding prior year period.
› Verified 9 days ago
Dr. Corby M Dixon, Dentist Medicare: Not Enrolled in Medicare Practice Location: 395 E 600 S, Preston, ID 83263 Phone: 208-852-0194 | |
Kurt Owen Iverson, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 135 S State St, Preston, ID 83263 Phone: 208-852-3700 Fax: 208-852-3777 | |
Dr. Thomas Richard Hull, D.D.S. Dentist Medicare: Medicare Enrolled Practice Location: 35 S State St, Preston, ID 83263 Phone: 208-852-0194 Fax: 208-852-3817 | |
Dr. Brett D. Naylor, D.D.S. Dentist Medicare: Medicare Enrolled Practice Location: 25 N 1st E, Preston, ID 83263 Phone: 208-852-0770 Fax: 208-852-3294 | |
Dr. Darron Harris Kelley, DDS Dentist Medicare: Medicare Enrolled Practice Location: 35 S State St, Preston, ID 83263 Phone: 208-852-2564 Fax: 208-852-3626 | |
Dr. Derek J Stokes, DDS Dentist Medicare: Medicare Enrolled Practice Location: 35 S State St, Suite A, Preston, ID 83263 Phone: 208-852-2561 Fax: 208-852-3626 |